Feed:Trial Acronyms: Difference between revisions

Jump to navigation Jump to search
Replaced content with "{ "trial_acronyms" : {} }"
No edit summary
(Replaced content with "{ "trial_acronyms" : {} }")
Line 1: Line 1:
{
{
   "trial_acronyms" : {
   "trial_acronyms" : {}
      "A-HeFT" : "African-American Heart Failure Trial",
      "SPARCL" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels",
      "RE-COVER" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism",
      "RALES" : "Randomized Aldactone Evaluation Study",
      "ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism",
      "TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban",
      "EASE" : "Early Surgery versus Conventional Treatment in Infective Endocarditis",
      "ISAR-REACT 5" : "Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5 Trial",
      "TRISS" : "Transfusion Requirements in Septic Shock",
      "TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome",
      "HEMO" : "Hemodialysis",
      "BEST" : "The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation",
      "ALBIOS" : "Albumin Italian Outcome Sepsis",
      "JUPITER" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin",
      "ESCAPE" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness",
      "PIONEER-HF" : "comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode",
      "ICAP" : "Evaluation of additive benefit of colchicine to conventional therapy in acute pericarditis",
      "ANNEXA" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors",
      "STAMPEDE" : "Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently",
      "EUROPA" : "European Trial on Reduction of Cardiac Events with Perindopril in Patients with Stable Coronary Artery Disease",
      "DPP" : "Diabetes Prevention Program",
      "WISDOM" : "Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management",
      "PCPT" : "Prostate Cancer Prevention Trial",
      "HEAT" : "Permissive Hyperthermia through Avoidance of Acetaminophen in Known or Suspected Infection in the Intensive Care Unit",
      "COPERNICUS" : "Carvedilol Prospective Randomized Cumulative Survival",
      "SCD-HeFT" : "Sudden Cardiac Death in Heart Failure Trial",
      "Look AHEAD" : "Look Action for HEAlth in Diabetes",
      "HEARTMATE II" : "Advanced heart failure treated with continuous-flow left ventricular assist device",
      "CABANA" : "Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation",
      "RE-LY" : "Randomized Evaluation of Long-Term Anticoagulation Therapy",
      "TREAT" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy",
      "SPYRAL HTN-ON MED" : "Global Clinical Study of Renal Denervation With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy",
      "CORAL" : "Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis",
      "SYNTAX" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery",
      "PIOPED II" : "Prospective Investigation of Pulmonary Embolism Diagnosis II",
      "EUCLID" : "Examining use of ticagrelor in peripheral artery disease",
      "COAPT" : "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation",
      "Oscillate" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early",
      "ATLAS" : "Adjuvant Tamoxifen: Longer Against Shorter",
      "IDEAL-ICU" : "Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit",
      "DIVA" : "Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty",
      "TIMACS" : "The Timing of Intervention in Acute Coronary Syndromes",
      "NINDS" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study",
      "PARADIGM-HF" : "Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure",
      "TRITON-TIMI 38" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38",
      "HYVET" : "Hypertension in the Very Elderly Trial",
      "CREDENCE" : "Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluation",
      "PRORATA" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients",
      "PROFESS" : "Prevention Regimen for Effectively Avoiding Second Strokes",
      "CANTOS" : "Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)",
      "TALC" : "Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid",
      "AASK" : "African American Study of Kidney Disease and Hypertension",
      "NORSTENT" : "Drug-Eluting or Bare-Metal Stents for Percutaneous Coronary Intervention in Stable or Unstable Coronary Artery Disease",
      "CHOIR" : "Correction of Hemoglobin and Outcomes in Renal Insufficiency",
      "BASALT" : "Best Adjustment Strategy for Asthma in the Long Term",
      "SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial",
      "AMAZES" : "Azithromycin on Asthma Exacerbations and Quality of Life in Adults With Persistent Uncontrolled Asthma",
      "POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm",
      "POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial",
      "CvLPRIT" : "Complete Versus Lesion-Only Primary PCI Trial",
      "CATIE" : "Clinical Antipsychotic Trials of Intervention Effectiveness",
      "ACCORD BP" : "ACCORD Study Group",
      "FAME 2" : "FFR vs. Angiographyfor Multivessel Evaluation 2",
      "ARDSNet" : "Acute Respiratory Distress Syndrome Network",
      "SPICE III" : "Sedation Practice in Intensive Care Evaluation",
      "OVIVA" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection",
      "DAWN" : "DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo",
      "ProCESS" : "Protocolized Care for Early Septic Shock",
      "ADVANCE" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation",
      "ARISE" : "Australasian Resuscitation in Sepsis Evaluation",
      "CREST" : "Carotid Revascularization Endarterectomy vs. Stenting Trial",
      "SPACE" : "Strategies for Prescribing Analgesics Comparative Effectiveness",
      "DOSE" : "Diuretic Optimization Strategies Evaluation",
      "PROSEVA" : "Proning Severe ARDS Patients",
      "WASID" : "Warfarin-Aspirin Symptomatic Intracranial Disease",
      "SAFE" : "Saline versus Albumin Fluid Evaluation",
      "MADIT-CRT" : "Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy",
      "POET" : "Partial Oral Treatment of Endocarditis",
      "SPS3-BP" : "Secondary Prevention of Small Subcortical Strokes-Blood Pressure",
      "CHANCE" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events",
      "CORTICUS" : "Corticosteroid Therapy of Septic Shock",
      "UKPDS" : "United Kingdom Prospective Diabetes Study",
      "AIRTRIP" : "AnakInRa for Treatment of Recurrent Idiopathic Pericarditis",
      "AFFIRM" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management",
      "EINSTEIN CHOICE" : "Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism",
      "COURAGE" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation",
      "AVOID" : "Comparing Oxygen with normal air in patients with ST-Segment Elevation Myocardial Infarction who are not hypoxic.",
      "SAVE" : "Survival and Ventricular Enlargement Trial",
      "PIONEER AF-PCI" : "Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with AF who Undergo Percutaneous Coronary Intervention",
      "BLOCK-HF" : "Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block",
      "NASCET" : "North American Symptomatic Carotid Endarterectomy Trial",
      "CAPRICORN" : "Carvedilol Post-Infarct Survival Control in LV Dysfunction",
      "ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group",
      "CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2",
      "3C" : "Cough Complication Cohort",
      "CHOICE" : "CHOICE is not an abbreviation per a communication with the research team",
      "SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism",
      "AMPLIFY" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy",
      "PRECISION" : "Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen",
      "AIDA" : "Amsterdam Investigator-Initiated Absorb Strategy All-Comers Trial",
      "PARTNER 3" : "Placement of Aortic Transcatheter Valves 3",
      "V-HeFT" : "Vasodilator Heart Failure Trial",
      "EPCAT II" : "Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty II",
      "TTM" : "Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest",
      "COGENT" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial",
      "COMMIT/CCS-2" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study",
      "GUSTO" : "Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries",
      "SOCRATES" : "Ticagrelor versus aspirin in stroke/TIA",
      "PROWESS-SHOCK" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock",
      "HOPE" : "Heart Outcomes Prevention Evaluation",
      "AVERROES" : "Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment",
      "HACA" : "Hypothermia After Cardiac Arrest",
      "CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance",
      "DAPA-HF" : "Dapagliflozin in Heart Failure",
      "RAVE" : "Rituximab in ANCA-Associated Vasculitis",
      "ARREST" : "Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia",
      "IDNT" : "Irbesartan Diabetic Nephropathy Trial",
      "SOAP II" : "Sepsis Occurrence in Acutely Ill Patients II",
      "MERIT-HF" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure",
      "NSABP B-32" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32",
      "CLOSURE I" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale",
      "RAFT" : "Resynchronization–Defibrillation for Ambulatory Heart Failure",
      "SPAF" : "Stroke Prevention in Atrial Fibrillation",
      "TRIUMPH" : "Transfusion Reduction Efficacy and Safety Clinical Investigation, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria",
      "VADT" : "Veterans Affairs Diabetes Trial",
      "PREPIC 2" : "Prevention du Risque d'Embolie Pulmonaire par Interruption Cave 2",
      "MOMENTUM 3" : "Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3",
      "ERSPC" : "European Randomized Study of Screening for Prostate Cancer",
      "PREPIC" : "Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group",
      "TRICC" : "Transfusion Requirements in Critical Care",
      "REDUCE-IT" : "Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial",
      "REDUCE" : "Reduction in the Use of Corticosteroids in Exacerbated COPD",
      "HERA" : "Herceptin Adjuvant Trial",
      "BARI 2D" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes",
      "DANISH" : "Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality",
      "DANAMI-3 PRIMULTI" : "Third Danish Study of Optimal Acute Treatment of Patients with STEMI: Primary PCI in Multivessel Disease",
      "PANTER" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis",
      "RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure",
      "ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial",
      "B-CONVINCED" : "Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode",
      "EDIC" : "Epidemiology of Diabetes Interventions and Complications",
      "RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan",
      "FAIR-HF" : "IV Iron for Symptoms in Patients with HFrEF and Iron Deficiency",
      "Blood-Pressure Reduction in Black Barbershops" : "Blood-Pressure Reduction in Black Barbershops",
      "StiL" : "Study Group Indolent Lymphomas",
      "RESCUEicp" : "Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure",
      "ALLHAT" : "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial",
      "CLOT" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism",
      "TRICS III" : "Transfusion Requirements in Cardiac Surgery",
      "ISIS-2" : "Second International Study of Infarct Survival",
      "BeSt" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)",
      "PROVE IT-TIMI 22" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22",
      "EVEREST" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan",
      "CULPRIT-SHOCK" : "Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock",
      "NETT" : "National Emphysema Treatment Trial",
      "APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban",
      "MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk",
      "TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist",
      "DAPT" : "Dual Antiplatelet Therapy",
      "SPS3-Clopidogrel+ASA" : "Secondary Prevention of Small Subcortical Strokes clopidogrel+ASA",
      "CARRESS-HF" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure",
      "DASH" : "Dietary Approaches to Stop Hypertension",
      "MUSTT" : "Multicenter Unsustained Tachycardia Trial",
      "WOSCOPS" : "West of Scotland Coronary Prevention Study",
      "OASIS-5" : "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes",
      "V-HeFT II" : "Vasodilator Heart Failure Trial II",
      "FACTT" : "Fluids and Catheters Treatment Trial",
      "CIRT" : "Cardiovascular Inflammation Reduction Trial",
      "SOLVD" : "Studies of Left Ventricular Dysfunction",
      "MSH" : "Multicenter Study of Hydroxyurea in Sickle-Cell Anemia",
      "iPrEx" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")",
      "ORBIT-AF" : "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation",
      "EXTRA" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma",
      "EMBRACE" : "30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event",
      "SPRINT" : "Systolic Blood Pressure Intervention Trial",
      "iFR-SWEDEHEART" : "Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome",
      "RESPECT" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment",
      "CAST I" : "Cardiac Arrhythmia Suppression Trial",
      "LESS" : "Lumbar Epidural Steroid Injections for Spinal Stenosis",
      "RECOVERY" : "Randomized Evaluation of Covid-19 Therapy",
      "FEAST" : "Fluid Expansion as Supportive Therapy",
      "TNT" : "Treating to New Targets",
      "ACTT-1" : "Adaptive Covid-19 Treatment Trial",
      "DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients",
      "CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events",
      "IRONOUT-HF" : "Iron Repletion Effects on Oxygen Uptake in Heart Failure",
      "ACOSOG Z0011" : "The American College of Surgeons Oncology Group (ACOSOG) Z0011",
      "MADIT-II" : "Multicenter Automatic Defibrillator Implantation Trial II",
      "AATAC" : "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device",
      "TIPPS" : "Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia",
      "DCCT" : "Diabetes Control and Complications Trial",
      "4S" : "Scandinavian Simvastatin Survival Study",
      "ONTARGET" : "Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial",
      "ACCORD Lipid" : "Action to Control Cardiovascular Risk in Diabetes-Lipid",
      "PEITHO" : "Pulmonary Embolism Thrombolysis trial",
      "EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study",
      "LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results",
      "MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin",
      "PROTECT AF" : "WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation",
      "CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections",
      "STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression",
      "EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)",
      "FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease",
      "STOP-IT" : "Study to Optimize Peritoneal Infection Therapy",
      "AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients",
      "CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer",
      "EVOLVE" : "Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis",
      "AUGUSTUS" : "An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention",
      "FAME" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation",
      "CHARM-Preserved" : "Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved",
      "ACURASYS" : "ARDS et Curarisation Systematique",
      "ADJUST-PE" : "Age aDJUSTed D-Dimer to rule out PE",
      "DETO2X-AMI" : "Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction",
      "MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients",
      "PREDIMED" : "Prevención con Dieta Mediterránea",
      "PLATO" : "Platelet Inhibition and Patient Outcomes",
      "ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention",
      "ART" : "Arterial Revascularization Trial",
      "IRIS" : "International Randomized Study of Interferon and STI571",
      "ASCEND" : "Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis",
      "VANISH" : "Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs",
      "ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial",
      "ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock",
      "DINAMIT" : "Defibrillator in Acute Myocardial Infarction Trial",
      "ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation",
      "PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis",
      "ENGAGE AF-TIMI 48" : "Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48",
      "CAMERA" : "Computer Assisted Management in Early Rheumatoid Arthritis",
      "COMPASS" : "Cardiovascular Outcomes for People Using Anticoagulation Stratgies",
      "STAR" : "Study of Tamoxifen and Raloxifene (NSABP P-2)",
      "MPACT" : "Metastatic Pancreatic Adenocarcinoma Clinical Trial",
      "DONATE HCV" : "Donors of Hepatitis C NAT Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients",
      "PARTNER A" : "Placement of Aortic Transcatheter Valves, Cohort A",
      "SHIFT" : "Systolic Heart failure treatment with the If inhibitor ivabradine Trial",
      "SONIC" : "Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease",
      "MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering",
      "NCDS" : "The National Cooperative Dialysis Study",
      "PARAGON-HF" : "Prospective Comparison of ARNI Global Outcomes in HF with Preserved Ejection Fraction",
      "ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events",
      "SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam",
      "TRED-HF" : "Treatment for heart failure in patients with recovered dilated cardiomyopathy",
      "GISSI-3" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico",
      "PRAMI" : "Preventative Angioplasty in Acute Myocardial Infarction",
      "RACE II" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II",
      "AURORA" : "A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events",
      "IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II",
      "VITAMINS" : "The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial",
      "PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A",
      "VEST" : "Vest Prevention of Early Sudden Death",
      "LoDoCo" : "Low-Dose Colchicine",
      "CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition",
      "NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design",
      "RE-ALIGN" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement",
      "ASPREE" : "Aspirin in Reducing Events in the Elderly",
      "CANVAS" : "Canagliflozin Cardiovascular Assessment Study",
      "SEPSISPAM" : "Sepsis and Mean Arterial Pressure",
      "AKIKI" : "Artificial Kidney Initiation in Kidney Injury",
      "ALMS" : "Aspreva Lupus Management Study",
      "ECST" : "European Carotid Surgery Trial",
      "DEFINITE" : "Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation",
      "WHI E+P" : "Women's Health Initiative Estrogen and Progestin Trial",
      "RE-DUAL PCI" : "Randomized evaluation of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin in patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention",
      "HPS2-THRIVE" : "Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events",
      "COMET" : "Carvedilol Or Metoprolol European Trial",
      "NSABP P-1" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1",
      "VASST" : "Vasopressin and Septic Shock Trial",
      "IALT" : "International Adjuvant Lung Cancer Trial",
      "EMILIA" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer",
      "WOEST" : "What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing",
      "ATLAS ACS 2-TIMI 51" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51",
      "RELAX" : "Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction",
      "ACCORD" : "Action to Control Cardiovascular Risk in Diabetes",
      "VA NEPHRON-D" : "Veterans Affairs Nephropathy in Diabetes",
      "Val-HeFT" : "Valsartan Heart Failure Trial",
      "CRISTAL" : "Colloids Versus Crystalloids for the Resuscitation of the Critically Ill",
      "HPS" : "Heart Protection Study Statin Arm",
      "MIND-USA" : "Modifying the Impact of ICU-Associated Neurological Dysfunction–USA",
      "CATT" : "Comparison of Age-Related Macular Degeneration Treatment Trails",
      "PRODIGE 4 ACCORD 11" : "PRODIGE 4 Actions concertées dans les Cancers COloRectaux et Digestifs",
      "EDS" : "European Dexamethasone Study",
      "SUP-ICU" : "Stress Ulcer Prophylaxis in the Intensive Care Unit",
      "ROCKET AF" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation",
      "ECASS III" : "European Cooperative Acute Stroke Study III",
      "NLST" : "National Lung Screening Trial",
      "SALT-ED" : "Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department",
      "COLCOT" : "Colchicine Cardiovascular Outcomes Trial",
      "ISAR-TRIPLE" : "Triple therapy in Patients who Require Oral Anticoagulation After Drug-Eluting Stent Implantation",
      "RAMPART" : "Rapid Anticonvulsant Medication Prior to Arrival Trial",
      "ADRENAL" : "Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock",
      "MASS" : "Multicentre Aneurysm Screening Study",
      "IMPROVE-IT" : "IMProved Reduction of Outcomes: Vytorin Efficacy International Trial",
      "POP-UP" : "Pantoprazole or Placebo for Stress Ulcer Prophylaxis",
      "BRIDGE" : "Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for Elective Invasive Procedure or Surgery",
      "PESIT" : "Pulmonary Embolism in Syncope Italian Trial",
      "CURE" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events",
      "FOCUS" : "Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair",
      "CASTLE-AF" : "Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation",
      "ORBITA" : "Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina",
      "ATN" : "Acute Renal Failure Trial Network Study",
      "TORCH" : "Towards a Revolution in COPD Health",
      "ANNEXA-4" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors",
      "TONE" : "Trial of Nonpharmacologic Interventions in the Elderly",
      "STOPAH" : "Steroids or Pentoxifylline for Alcoholic Hepatitis",
      "REMATCH" : "Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure",
      "BICAR-ICU" : "Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill: A Multiple Center Randomized Clinical Trial",
      "AAPAC" : "Appendicitis Acuta",
      "MIDA" : "Mitral Regurgitation International Database",
      "VALIANT" : "Valsartan in Acute Myocardial Infarction Trial",
      "UKPDS 34" : "UK Prospective Diabetes Study 34",
      "BRIM-3" : "BRAF Inhibitor in Melanoma 3",
      "PARTNER B" : "Placement of Aortic Transcatheter Valves, Cohort B",
      "CYTO-PV" : "Cytoreductive Therapy in Polycythemia Vera",
      "AMPLIFY-EXT" : "Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment",
      "FLAME COPD" : "Effect of Indacaterol Glycopyronium Vs. Fluticasone Salmeterol on COPD Exacerbations",
      "CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study",
      "STICH" : "Surgical Treatment for Ischemic Heart Failure",
      "HOPE-3" : "Heart Outcomes Prevention Evaluation-3",
      "ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade",
      "ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial",
      "ASTRAL" : "Angioplasty and Stenting for Renal Artery Lesions",
      "DIG" : "Digitalis Investigation Group",
      "FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke",
      "RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes",
      "METEOR" : "Meniscal Tear in Osteoarthritis Research",
      "CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure",
      "AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure",
      "NOTT" : "Nocturnal Oxygen Therapy Trial",
      "WARFASA" : "Warfarin and Aspirin",
      "IDEAL" : "Initiating Dialysis Early and Late",
      "SADHAT" : "Sertraline Antidepressant Heart Attack Randomized Trial",
      "CATIE-AD" : "Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease",
      "MOPETT" : "Moderate Pulmonary Embolism Treated with Thrombolysis",
      "NICE-SUGAR" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation",
      "ACTIVE A" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events",
      "NEAT-HFpEF" : "Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction",
      "ELITE-Symphony" : "Efficacy Limiting Toxicity Elimination-Symphony",
      "IST" : "International Stroke Trial",
      "ATTRACT" : "Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis",
      "FOURIER" : "Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk",
      "DODS" : "D-dimer Optimal Duration Study",
      "ACCOMPLISH" : "Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension",
      "HPTN 052" : "HIV Prevention Trials Network 052 Study",
      "SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement",
      "OAT" : "Occluded Artery Trial",
      "EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure",
      "POISE" : "PeriOperative ISchemic Evaluation",
      "UPLIFT" : "Understanding Potential Long-Term Impacts on Function with Tiotropium",
      "CSG Captopril Trial" : "Collaborative Study Group Captopril Trial",
      "ODYSSEY LONG TERM" : "Long-term Safety and Tolerability of Alirocumab in High Cardiovascular Risk Patients with Hypercholesterolemia Not\nAdequately Controlled with Their Lipid Modifying Therapy",
      "SHOCK" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK"
  }
}
}
Bots, editor, reviewer, Administrators
13,941

edits

Navigation menu